CLINICAL_TRIALS
trial_result
· 2023-10-23
Clinical Trial Update: Safety, Tolerability, and Pharmacokinetic Study of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis [Phase 1]
Summary
Phase 1 trial assessing safety, tolerability, and pharmacokinetics of TRK-250 in idiopathic pulmonary fibrosis completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Toray Industries, Inc | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: COMPLETED | Results posted: 2023-10-23